ArticleMelanoma research2018
Analysis of MLN4924 (pevonedistat) as a potential therapeutic agent in malignant melanoma.
Gonzalo N Olaverria Salavaggione et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
5 papers cite it
this papercites it